Leukemia, Myelodysplasia, Transplantation

News

JAK2 inhibitor could treat B-ALL

Photo courtesy of the Dana-Farber Cancer Institute A type II JAK2 inhibitor has shown activity against B-cell acute lymphoblastic leukemia (B-ALL...

Conference Coverage

Index discriminates prognostic groups in CLL

Key clinical point: An international prognostic index for patients with chronic lymphocytic leukemia may help to inform treatment decisions. Major...

Pages